Towards a reference case for economic evaluation of osteoporosis treatments.
Coyle
Douglas
D
Faculty of Medicine, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Health Research Institute, Ottawa Hospital, Ottawa, Canada. dcoyle@ohri.ca
Tosteson
Anna N
AN
D018501:Antirheumatic Agents / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D006801:Humans; D018803:Models, Economic; D010024:Osteoporosis / Q000188:drug therapy / Q000191:economics; D015397:Program Evaluation / Q000191:economics / Q000379:methods / Q000592:standards*; D012015:Reference Standards; D012219:Rheumatology / Q000191:economics*
D018501:Antirheumatic Agents